VERORABVAX, created in 2011 (France), from 2757 sister brands and 17478 competing brands. VERORABVAX is a brand of SANOFI, listed on the stock exchange of Paris. Its International Securities Identification Number (ISIN) is FR0000120578. VERORABVAX is part of the Drug Manufacturers activity sector.